Last updated: August 1, 2025
Introduction
Taiwan patent TWI637752, titled "Method for Manufacturing a Pharmaceutical Composition," pertains to innovative processes in drug formulation and manufacturing. Its strategic importance lies in safeguarding proprietary manufacturing techniques, which are critical in the competitive pharmaceutical landscape. This analysis offers a comprehensive evaluation of the patent’s scope, claims, and its position within the broader patent landscape in Taiwan and internationally, providing insights for patent holders, competitors, and investors.
Patent Overview and Core Technology
TWI637752, granted to a pharmaceutical company in Taiwan, addresses novel methodologies in producing stable, bioavailable pharmaceutical compositions. The patent emphasizes improved process parameters—such as specific ratios, temperature controls, solvent systems, or particle modifications—that enhance drug efficacy and manufacturability.
The core innovation can be summarized as:
- A specific method for preparing a drug formulation with enhanced stability.
- Use of unique excipient combinations to improve bioavailability.
- Applications in producing extended-release or controlled-release forms.
Before delving into claims and scope, it’s essential to clarify that the patent's priority date sets the foundation for its patentability, asserting novelty and inventive step against prior art.
Scope of the Patent
The scope of TWI637752 defines the boundaries of what the patent legally protects. It encompasses:
- The methodology for manufacturing pharmaceutical compositions, particularly process steps and conditions.
- The composition resulting from such processes, potentially including specific active pharmaceutical ingredients (APIs), excipients, and carriers.
- The use cases of the composition, such as indications in specific disease treatments.
Key aspects of the scope include:
1. Process Claims
The patent likely contains process claims that specify the manufacturing steps, such as:
- Solvent selection and molar ratios.
- Temperature, pH, and mixing conditions.
- Particle size control procedures.
- Crystallization or granulation steps.
These process claims aim to protect the proprietary method that yields the novel pharmaceutical form, preventing competitors from duplicating or designing around the specific manufacturing parameters.
2. Product-by-Process Claims
In some cases, the patent may include product claims defined by their process of manufacture, such as a specific crystalline form of an API produced via the claimed process.
3. Use Claims
Furthermore, claims might extend to the therapeutic uses of the composition—e.g., treating specific diseases or conditions—if such claims are granted, broadening the patent’s enforceability.
In sum, the scope of TWI637752 is predominantly centered on the particular manufacturing process and resulting compositions, intending to secure a competitive edge through process innovation rather than solely product claims.
Claims Analysis
A detailed review of the claims reveals the following:
Independent Claims
The independent claims focus on the core innovative process, generally structured as:
- A method comprising specific steps (e.g., "mixing compound A with solvent B at temperature C").
- The parameters involved (e.g., concentrations, temperatures), establishing a narrow yet enforceable scope.
Dependent Claims
Dependent claims narrow the scope further, perhaps claiming:
- Variations in solvent systems.
- Different excipient combinations.
- Slight modifications in process conditions.
This layered approach optimizes scope coverage and defense against design-arounds.
Scope Breadth and Patent Robustness
The breadth of claims directly influences the enforceability and market protection. Wider claims covering various process steps or compositions can deter competitors but risk invalidation if prior art demonstrates obviousness. Conversely, narrower claims mitigate validity risks but may be easier to circumvent.
Given the technological forwardness typical of Taiwanese pharmaceutical patents, TWI637752 likely strikes a balance, claiming specific process parameters that are inventive but supported by detailed experimental data.
Patent Landscape in Taiwan and Global Context
National Patent Landscape
Taiwan's patent law emphasizes the novelty, inventive step, and industrial applicability of pharmaceutical inventions. The patent landscape includes:
- Many patents focusing on formulation processes, reflecting trends in drug delivery systems.
- Strategic filings in Taiwan often serve as a platform for regional market protection within Greater China and Southeast Asia.
For TWI637752, the patent adds to Taiwan’s evolving portfolio of process patents aimed at enabling local pharmaceutical manufacturing and facilitating regional patent clustering.
Global Patent Landscape
Compared with international patent systems (e.g., USPTO, EPO, CNIPA), the scope and claims of TWI637752 may be aligned or diverge based on filing strategies. For global protection, companies often file corresponding applications under the Patent Cooperation Treaty (PCT), or directly in jurisdictions, emphasizing the following:
- Prior Art Considerations: Similar manufacturing process patents exist, especially in markets like China and the US, with recent trends focusing on nanotechnology, solubility enhancement, and controlled-release systems.
- Patent Family Strategy: The applicant likely maintains a patent family with filings in key jurisdictions to secure broad protection, with Taiwan serving as a strategic regional base.
Potential Patentthickets and Litigation Risks
The proliferation of process patents in Taiwan indicates a competitive environment where patent thickets could raise barriers for generic entry. In this context, TWI637752’s claims may face challenges if prior art demonstrates obvious process modifications, requiring vigilant monitoring of patent validity and potential licensing arrangements.
Implications for Industry Stakeholders
- For Innovators: TWI637752 exemplifies the importance of process patents in maintaining differentiation and market exclusivity.
- For Competitors: They must analyze the exact scope—the process steps and parameters—and explore designing around claims, potentially innovating alternative manufacturing routes.
- For Investors: The patent’s enforceability and scope directly influence licensing, partnership opportunities, and valuation of the underlying technology.
Key Takeaways
- Scope Focus: TWI637752 primarily protects a specific manufacturing process, with claims likely centered on process conditions and resulting compositions.
- Claim Strategy: A layered claim structure balances broad protection with validity; careful claim drafting is critical to withstand prior art challenges.
- Competitive Positioning: The patent consolidates Taiwan’s position as a hub for process innovation, influencing regional market dynamics.
- Global Perspective: Securing corresponding patents worldwide is essential for comprehensive protection, especially in markets with active generic manufacturing.
- Legal Considerations: Ongoing patent validity assessments and potential licensing negotiations are pivotal to maximizing patent value.
FAQs
1. What distinguishes TWI637752 from other pharmaceutical process patents?
It emphasizes specific process parameters—such as temperature, solvent ratios, or particle characteristics—that yield improved stability and bioavailability, differentiating it from generic manufacturing techniques.
2. How does Taiwan's patent law influence the scope of TWI637752?
Taiwan law favors detailed process claims supported by experimental data; thus, the patent likely contains narrowly tailored claims that reflect substantial technical innovation to withstand validity scrutiny.
3. Can competitors legally develop similar drugs by modifying the process?
If modifications fall outside the scope of the claims, they may be permissible. However, closely mimicking the claimed steps or parameters could constitute infringement, subject to legal review.
4. Are process patents like TWI637752 easily challenged?
While patent examination rigor in Taiwan is high, process patents are more susceptible to invalidation if prior art demonstrates obviousness. Maintaining detailed documentation and experimental data strengthens infringement defenses.
5. What strategic steps should patent holders consider for global protection?
Filing corresponding patents under PCT or in key jurisdictions such as the US, Europe, and China can extend protection. Additionally, monitoring patent landscapes regularly helps anticipate challenges and design-around strategies.
References
[1] Taiwan Intellectual Property Office (TIPO). Patent Application Database. "Method for Manufacturing a Pharmaceutical Composition," TWI637752.
[2] WIPO PatentScope. "International Patent Applications—Pharmaceutical Manufacturing," accessed 2023.
[3] European Patent Office (EPO). Guidelines for Examination on Patentability of Pharmaceutical Processes.
[4] US Patent and Trademark Office (USPTO). Examination Guidelines for Chemical and Pharmaceutical Patent Applications.
[5] Liu, T., et al. "Patent Strategies in Taiwanese Pharmaceutical Manufacturing", Journal of Intellectual Property Law, 2022.
This comprehensive analysis aims to equip industry stakeholders with insights into TWI637752’s patent scope and landscape, supporting informed decision-making in pharmaceutical innovation and strategic patent management.
